Overexpression of P4HB was notably associated with inferior outcomes, and knocking down P4HB impeded cell proliferation and enhanced GEM sensitivity via the PERK/eIF2α/ATF4/CHOP signaling pathways in BLCA (44). Here, ATF4 is linked to bladder transitional cell carcinoma.